Name
GS01-03 - Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy:interim analysis of the ALEXANDRA/IMpassion030 phase 3 trial. (China)
Date & Time
Wednesday, December 20, 2023
Speakers
Virtual Session Link